|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,522.00 JPY | -0.37% |
|
+0.97% | -8.75% |
| 06-15 | Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen | MT |
| 05-26 | Major Asian Stock Markets Fall Amid Renewed Middle East Tensions | MT |
| Market Cap | 12,379B 76.58B 67.02B 61.9B 57.84B 108B 7,253B 109B 731B 285B 3,562B 288B 281B | P/E 2026 * |
24.3x | P/E 2027 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise Value | 11,457B 70.87B 62.03B 57.28B 53.53B 100B 6,712B 101B 676B 264B 3,296B 266B 260B | EV / Sales 2026 * |
8.26x | EV / Sales 2027 * | 7.3x |
| Free-Float |
38.12% | Yield 2026 * |
1.82% | Yield 2027 * | 2.08% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -0.37% | ||
| 1 week | +0.97% | ||
| Current month | -4.69% | ||
| 1 month | -4.01% | ||
| 3 months | -13.04% | ||
| 6 months | -9.28% | ||
| Current year | -8.75% |
| 1 week | 7,386 | 7,719 | |
| 1 month | 7,270 | 8,215 | |
| Current year | 7,270 | 10,700 | |
| 1 year | 5,942 | 10,700 | |
| 3 years | 3,767 | 10,700 | |
| 5 years | 3,191 | 10,700 | |
| 10 years | 1,003.33 | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 2020-12-31 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 2024-03-27 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Motoo Ueno
BRD | Director/Board Member | 68 | 1993-02-28 |
Masayuki Oku
BRD | Director/Board Member | 81 | 2015-02-28 |
| Director/Board Member | 77 | 2017-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.37% | +0.97% | +4.63% | +74.77% | 77.05B | ||
| +0.32% | -2.73% | +44.49% | +143.28% | 980B | ||
| +1.27% | -3.98% | +54.41% | +41.13% | 550B | ||
| +6.25% | +1.00% | +24.13% | +68.06% | 382B | ||
| +0.25% | -3.09% | +23.33% | +16.78% | 316B | ||
| +0.42% | -1.28% | +27.89% | +14.71% | 272B | ||
| +1.67% | -1.47% | +26.76% | +32.88% | 268B | ||
| +2.39% | +4.42% | -36.96% | -45.12% | 199B | ||
| +2.11% | -2.95% | +19.14% | +51.83% | 182B | ||
| +0.90% | -0.57% | +15.09% | +60.89% | 154B | ||
| Average | +0.74% | -2.29% | +20.29% | +45.92% | 337.94B | |
| Weighted average by Cap. | +0.53% | -3.39% | +30.67% | +65.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,387B 8.58B 7.51B 6.93B 6.48B 12.15B 813B 12.26B 81.86B 31.98B 399B 32.23B 31.53B | 1,535B 9.5B 8.31B 7.68B 7.17B 13.44B 899B 13.57B 90.6B 35.4B 442B 35.68B 34.9B |
| Net income | 509B 3.15B 2.75B 2.54B 2.38B 4.46B 298B 4.5B 30.03B 11.73B 146B 11.82B 11.57B | 593B 3.67B 3.21B 2.97B 2.77B 5.19B 348B 5.24B 35.01B 13.68B 171B 13.79B 13.49B |
| Net Debt | -923B -5.71B -4.99B -4.61B -4.31B -8.08B -540B -8.16B -54.45B -21.27B -265B -21.44B -20.98B | -1,166B -7.21B -6.31B -5.83B -5.45B -10.21B -683B -10.31B -68.8B -26.88B -335B -27.09B -26.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-22 | 7,522.00 ¥ | -0.37% | 1,238,100 |
| 26-06-19 | 7,550.00 ¥ | -0.21% | 3,697,700 |
| 26-06-18 | 7,566.00 ¥ | -1.10% | 1,954,000 |
| 26-06-17 | 7,650.00 ¥ | +1.69% | 1,745,000 |
| 26-06-16 | 7,523.00 ¥ | +1.28% | 2,083,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions


















